Completed

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer (neoMONARCH)

I3Y-MC-JPBY - ClinicalTrials.gov - NCT02441946

The purpose of this study is to evaluate the biological effects of abemaciclib in combination with anastrozole and compare those to the effects of abemaciclib alone and anastrozole alone in the tumors of postmenopausal women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 (HER2) negative breast cancer.
How long will I be in the trial?
Your participation could last up to 10 months depending on how you and your tumor respond.
Email
Completed

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer (neoMONARCH)

I3Y-MC-JPBY - ClinicalTrials.gov - NCT02441946

The purpose of this study is to evaluate the biological effects of abemaciclib in combination with anastrozole and compare those to the effects of abemaciclib alone and anastrozole alone in the tumors of postmenopausal women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 (HER2) negative breast cancer.
How long will I be in the trial?
Your participation could last up to 10 months depending on how you and your tumor respond.
Email

Key Requirements

Age :

18+

Sex:

Female

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

Female

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Non-Metastatic Breast Cancer, Solid Tumor

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

220

Trial Dates

August 2015 - February 2018

Trial Phase

2

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

Female

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Non-Metastatic Breast Cancer, Solid Tumor

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

220

Trial Dates

August 2015 - February 2018

Trial Phase

2

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?